Progress is characterised by strong sector engagement and support for the Plan, increasing alignment of sector activities to the Plan’s priorities, and the establishment of enabling infrastructure to support longer-term system change and intended outcomes.
Activity is strongest in prevention and early detection, consumer experience, and system foundations, reflecting the Plan’s early emphasis on establishing frameworks and enabling infrastructure. Workforce and Aboriginal and Torres Strait Islander equity demonstrate important early progress but require further scaling and sustained effort.
This is strengthening alignment between jurisdictions and sectors, shaping policy priorities, and supporting collaboration. It is also influencing organisational strategies, funding bids, and planning processes, with alignment to the Plan increasingly seen as a marker of credibility and strategic relevance.
The Plan has moved equity — particularly Aboriginal and Torres Strait Islander cancer outcomes — from a principle dependent on individual leadership to a shared system-wide priority. This shift is evident in policy, funding, workforce development and service planning, supported by Indigenous-led initiatives and partnerships.
A lag between system-level reform and improvements in frontline delivery and outcomes, is to be reasonably expected at this stage of a 10-year reform agenda, where system-level foundations typically precede measurable frontline change. This is an issue warranting attention as the Plan moves toward its 5-year mark, when service-level change and outcomes should become more evident.
A distributed implementation model has been established, based on shared responsibility across governments, the cancer sector, and implementation partners. Governance and coordination mechanisms — including 36+ Implementation Partnerships (as of June 2026), advisory structures and engagement processes — are supporting collaboration, although many are still maturing.
At two years, the Plan has established strong national foundations, sector alignment and enabling infrastructure for the next phase of implementation.
333 initiatives underway across government and implementation partners
The Plan has established the foundations needed for long-term reform. The next phase is about translating those foundations into coordinated implementation at scale, clearer accountability and measurable progress toward the 5 year goals.
Implementation activity is particularly strong across prevention, risk reduction and early detection actions. Stakeholders are actively contributing through initiatives that support cancer prevention, screening participation, early diagnosis and public awareness. The breadth of activity suggests strong alignment with the Plan's ambition to reduce cancer incidence and improve outcomes through earlier detection.
A substantial volume of initiatives aligns with actions focused on consumer experience, supportive care, treatment pathways and person-centred care. Activity demonstrates strong commitment across the sector to improving cancer outcomes and experiences for people affected by cancer.
Implementation activity is evident across actions supporting high-quality, coordinated and sustainable cancer care. Stakeholder initiatives demonstrate ongoing efforts to strengthen health system performance, service integration and quality improvement.
Strong momentum is evident across actions relating to data, research, digital health, innovation and knowledge generation. Activity under this Strategic Objective reflects significant sector investment in the foundations required to support continuous learning and future system improvement.
Workforce-related initiatives are contributing to capability development, workforce planning and workforce sustainability. Activity demonstrates important progress in foundational workforce actions while highlighting opportunities to deepen implementation over the next phase of the Plan.
Foundational activity is evident across initiatives supporting Aboriginal and Torres Strait Islander leadership, culturally safe care and equity-focused reform. Continued investment and implementation will support progress towards longer-term equity objectives across the Plan.
This visual shows the breadth and relative volume of implementation activity mapped to each action in the Australian Cancer Plan, based on initiative data reported by stakeholders across the cancer control sector, including the Australian Government, state and territory governments, Implementation Partners of the Australian Cancer Plan, non-government and professional organisations, and Aboriginal and Torres Strait Islander organisations. Reporting is voluntary and evolving, and a single initiative may map to more than one action. The visual reflects activity reported to date and should be read as an indication of implementation activity across the sector contributing to the Plan. It does not assess the scale, quality, reach or impact of initiatives, or completion of actions.
The eight Key Evaluation Questions in the Monitoring and Evaluation Framework have been grouped into five thematic categories to support synthesis and reporting of evaluation findings.
Substantial implementation activity is underway, and the Plan is performing broadly as intended at this early stage of a deliberately ambitious 10-year reform agenda.
Read more >The Australian Cancer Plan is shaping system-level change. At the 2-year mark, the strongest effects are seen in improved national alignment, shaping policy, strengthening collaboration, and elevating equity across the cancer system. The focus is now shifting to frontline outcomes and patient experience.
Read more >The same factors that shape implementation also determine the Plan's ability to achieve lasting outcomes. Strong national leadership shared strategic direction, collaboration and dedicated investment have enabled progress, while funding, workforce and system constraints limit impact.
Read more >Positive unintended effects show the Plan is generating broader alignment and momentum. Implementation pressures highlight the need to manage workload, resourcing and coordination as delivery scales.
Read more >The Australian Cancer Plan has established a strong strategic foundation; sustained impact will depend on stronger implementation, accountability, capability building and adaptive planning.
Read more >The Plan has established a strong and credible foundation for long-term reform. The next phase requires a deliberate shift toward implementation at scale, supported by stronger capability, clearer accountability and sustained investment, to ensure that early system-level progress delivers measurable improvements in cancer outcomes and experiences for all Australians.
While there is strong support for the Plan, stakeholders consistently identified limited funding, workforce pressures, data challenges and governance complexities as barriers to progress. A deliberate shift is needed from establishing broad strategic directions to prioritising and resourcing delivery on the ground, with clear measures of success.
There is an opportunity to sharpen implementation focus by prioritising high-impact actions and strengthening coordinated delivery across governments and implementation partners. Greater clarity of roles, responsibilities and accountability, supported by Cancer Australia’s ongoing leadership, would strengthen coordination across the cancer control sector.
Coordinated implementation has the potential to reduce duplication and fragmentation and address gaps in the system. This includes an ongoing emphasis on exploring how the Plan, the Aboriginal and Torres Strait Islander Cancer Plan, and state and territory cancer plans complement one another as each mature and are delivered. In this context, monitoring and evaluation systems should continue to mature so future reporting can better assess reach, scale and impact across the full system.
While acknowledging the fundamental complexity of Australia’s federated system, there would be benefit in further engagement between the Commonwealth, state and territory governments, sector partners and the broader cancer control sector. Stakeholders also highlighted the importance of ongoing consumer engagement to increase visibility of the Plan and ensure lived experience continues to inform implementation and future evaluation.
Strengthening policy levers and accountability mechanisms could further embed the Plan’s priorities across the cancer control system and support consistent uptake of key activities.This needs to be supported by sustained investment in system capability to enable implementation at scale. This includes strengthening data infrastructure, workforce capacity and practical supports to translate national frameworks into consistent delivery across the system. In particular, continued support for Aboriginal and Torres Strait Islander leadership and key First Nations cancer measures is needed to sustain momentum and drive more equitable outcomes.
There are opportunities to build on and scale existing national frameworks, partnerships and initiatives. Continued implementation and integration of key frameworks and programs — including data, genomics, optimal care pathways and national networks — will be critical to translating early foundations into system-wide impact.
Coming soon - Australian Cancer Plan 2-year Evaluation Full Report. If you would like an advanced copy of the report, please contact australiancancerplan@canceraustralia.gov.au
Guided by the Australian Cancer Plan Monitoring and Evaluation Framework, the evaluation was led by Cancer Australia using a hybrid model that included an independent external evaluation team from the University of Melbourne to provide evaluation expertise. Governance arrangements included an Australian Cancer Plan 2-year Evaluation Expert Advisory Group, and oversight through existing Cancer Australia advisory structures, supporting methodological rigour, transparency and sector confidence.
Information to inform the evaluation was gathered from multiple data sources including implementation documentation and monitoring data, an online stakeholder survey, and targeted stakeholder consultations conducted from February - March 2026. Findings were analysed to identify consistent themes across stakeholder perspectives and data sources, while acknowledging variation in experience across stakeholder groups.
Stakeholder engagement to inform the evaluation included 82 unique stakeholders across 39 consultation sessions and 57 survey responses, including governments, the cancer control sector, Aboriginal and Torres Strait Islander stakeholders and consumers.